NCT06199882 2024-10-15
SBRT Sequential Surufatinib Combined With Immunotherapy for Biliary Tract Carcinoma
Zhejiang Cancer Hospital
Phase 2 Suspended
Zhejiang Cancer Hospital
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology